Centre for the Development of Industrial Technology (CDTI)
VC Fund
Madrid, Spain
Centre for the Development of Industrial Technology (CDTI) is a VC fund in Madrid focused on Biotechnology and Health Care. The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
- Total investments:
- 223
- Last investment:
- Lead investor:
- 41%
Last updated:
For AI agents: llms.txt
Industries Centre for the Development of Industrial Technology (CDTI) invests in
Stages Centre for the Development of Industrial Technology (CDTI) invests in
Countries Centre for the Development of Industrial Technology (CDTI) invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $576k–$5.8M
- Grant
- $167k–$15M
Investment Focus
Industry
- Biotechnology 35 (16%)
- Health Care 27 (12%)
- Software 23 (10%)
- Manufacturing 16 (7%)
- Information Technology 16 (7%)
Stage
- Funding Round 54 (24%)
- Grant 33 (15%)
- Seed 32 (14%)
- Series A 13 (6%)
- Series B 7 (3%)
Country
- Spain 121 (54%)
- United States 3 (1%)
- France 1 (0%)
- Mexico 1 (0%)
- United Kingdom 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ana Tapiador
Department of Education and Communication
|
Department of Education and Communication | Total investments: 0 | Find email | |
Flavia Marzano
Member
|
Member | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Connecta Therapeutics
|
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome. | $4.2M / Venture - Series Unknown / Sep 10, 2026 | |
MOA
|
MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food. | $3.8M / Venture - Series Unknown / Sep 03, 2026 | |
FuVeX
|
FuVeX is dedicated to the design, manufacture, and commercialization of drones. The vision of the members of FuVeX is to improve the way in which the great institutions and companies are related to the aeronautics. Moreover, the company's mission is to provide such institutions and companies with an aircraft that allows them to solve theirmonitoring or transportation needs by flying long distances in a safe, easy and legal way. | $461.5K / Grant / Aug 05, 2026 | |
Phoenix Foods
|
Phoenix Foods uses insect farming to solve the problems of organic waste management and the requirement for high-quality proteins in animal feed. | Grant / Jul 17, 2026 | |
Orga AI
|
Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain. | $2.9M / Grant / May 22, 2026 | |
Golden Owl
|
Golden Owl is an AI-powered business intelligence platform that delivers real-time insights through AI agents and open-source intelligence. It provides AI-driven business intelligence and risk analysis using a network of specialized AI agents. The platform gathers and analyzes open-source data to help organizations monitor markets, competitors,threats, and opportunities. It enables faster decision-making through automated intelligence collection, analytics, and conversational AI-powered insights. | $1.6M / Seed / Apr 09, 2026 | |
Xoople
|
Xoople operates as an earth intelligence company. Xoople powers the next generation of Earth data intelligence to achieve a systematic understanding of physical changes on the Earth’s surface. | $130M / Series B / Apr 06, 2026 | |
Peptomyc
|
Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market. | $5.8M / Venture - Series Unknown / Mar 24, 2026 | |
Oncomatryx
|
Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.Oncomatryx has developed precision drugs and diagnostic devices that target the tumor stroma.Oncomatryx Antibody-Drug Conjugates (ADCs) and human-derived proteins target peritumoral fibroblasts, endothelial cells and extracellular matrix that promote tumorinvasiveness, drug resistance and immunosuppression.Oncomatryx ADCs bear novel proprietary payloads and linker derivatives that render an optimal therapeutic index against pancreatic cancer in vivo. Oncomatryx OMTX705, an ADC which targets cancer-associated fibroblasts (CAFs), inhibits pancreatic tumor growth in patient-derived xenograft mice, both as single agent and in combination with chemotherapy. | $67.3M / Venture - Series Unknown / Mar 23, 2026 | |
Amelia Hub
|
Amelia is a a drone services company | $5.8M / Seed / Mar 11, 2026 | |
| See all 223 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Centre for the Development of Industrial Technology (CDTI) invest in?
Centre for the Development of Industrial Technology (CDTI) invests primarily in Biotechnology, Health Care and Software startups, most often at Funding Round and Grant stage. Most of the 223 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Centre for the Development of Industrial Technology (CDTI)'s check size?
Centre for the Development of Industrial Technology (CDTI) typically joins rounds of $576k–$5.8M at Seed and $167k–$15M at Grant. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Centre for the Development of Industrial Technology (CDTI) participates in.
How do I contact Centre for the Development of Industrial Technology (CDTI)?
Public channels for Centre for the Development of Industrial Technology (CDTI) include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Centre for the Development of Industrial Technology (CDTI)?
The team at Centre for the Development of Industrial Technology (CDTI) includes Ana Tapiador (Department of Education and Communication) and Flavia Marzano (Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
